IQVIA™ Real-World Insights Bibliography

The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study
Author(s): Gómez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, Pérez G3, Saah A3, Alemany L8
Affiliations(s): 1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain
Publication(s):  IPVC, Barcelona, Spain, 23-27 March 2020
Document Type(s): Oral presentation,
Countries: China, France, Germany, Italy, Japan, Portugal, Spain,
C:
Y:
Infectious disease, Oncology,
2020
  L:
A:
English
Burden of illness, Observational study, Retrospective Field Study,
  Add to report
 
 
Projected long-term clinical benefit and cost-effectiveness of empagliflozin compared to glimepiride in patients with type 2 diabetes in China
Author(s): Lamotte M1, Salem A2, Mettam S2, Ustyugova A2, Zhang YJ3, Ramos M1
Affiliations(s): 1 IQVIA, Zaventem, Belgium 2 Boehringer Ingelheim International, GmbH, Germany 3 Boehringer Ingelheim, Beijing, China
Publication(s):  ADA, San Francisco, US, 07-11 June 2019
Document Type(s): Poster,
Countries: China,
Click here for the abstract
C:
Y:
Diabetes,
2019
  L:
A:
English
Cost effectiveness, Population Based Study,
  Add to report
 
 
Contrasting three type 2 diabetes cardiovascular risk equations for East Asia with UKPDS82 using the IQIVA core diabetes model
Author(s): Olivieri A1, Ramos M2, Monteiro S3, Altrabsheh E3, Gurjar K4, Lamotte M2
Affiliations(s): 1 IQVIA, Basel, Switzerland 2 IQVIA, Zaventem, Belgium 3 IQVIA, London, UK 4 IQVIA, Gurgaon, India
Publication(s):  ISPOR, New Orleans, 18-22 May 2019
Document Type(s): Poster,
Countries: China,
C:
Y:
Diabetes,
2019
  L:
A:
English
Cost effectiveness, Population Based Study,
  Add to report
 
 
Natural hisotry of oral human papillomavirus infection in healthy populations: Design of the Prevalence of Oral HPV infection, a Global assessment, THE PROGRESS STUDY
Author(s): Pedros M1, Morais E2, Roset M1, Kothari S3, Alemany L5, Mirghani H6, Mehanna H7, Waterboer T8, Roberts C3, Vendetti N3, Walia A3, Drury R2, Luxembourg A3, Giuliano A9
Affiliations(s): 1 IQVIA, Barcelona, Spain 2 MSD, Lyon, France 3 Merck & Co, Inc., Kenilworth, NJ, US 5 Catalan Institute of Oncology, Cancer Epidemiology Research Program and IDIBELL i CIBERESP, Barcelona, Spain 6 Hôpital Européen Georges-Pompidou Université Paris-Descartes, Paris, France 7 Institute of Head & Neck Studies and Education (InHANSE), University of Birmingham, Birmingham, United kingdom 8 German Cancer Research Center (DKFZ), Heidelberg, Germany 9 Moffitt Cancer Center, Florida, US
Publication(s):  EUROGIN, Monaco, France, 4-7 December 2019
Document Type(s): Oral presentation,
Countries: China, France, Germany, Italy, Japan, Spain, UK, USA,
Click here for the abstract
C:
Y:
Clinical practice, Infectious disease, Methodology,
2019
  L:
A:
English
Epidemiological study, Observational study, Population Based Study,
  Add to report
 
 
Assessing the Burden of Type 2 Diabetes in China Considering the Current Status-Quo Management and Implications of Improved Management Using a Modeling Approach
Author(s): Foos V1, Wang K2, McEwan P3, Zhang Y2, Xin P2, Jiang X2, Qu S4, Xiong T4, De Moor R1, Ramos M1, Lamotte M1, Ji L5
Affiliations(s): 1 IQVIA, Zaventem, Belgium 2 Lilly Suzhou Pharmaceutical Co, Ltd, Shanghai, China 3 Centre for Health Economics, Swansea University, Wales, England, UK 4 RWE Solutions & HEOR, QuintilesIMS, Shanghai, China 5 Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China
Publication(s):  Value Health Reg Issues. 2019 May;18:36-46.
Document Type(s): Article,
Countries: China,
Click here for the abstract
C:
Y:
Diabetes, Health economics,
2019
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Initial Management of localised prostate cancer in the Elderly: An International Data Review
Author(s): Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R1, Payne H1
Affiliations(s): 1 University College Hospital, London, UK 2 IQVIA , London, UK
Publication(s):  SIOG 2018
Document Type(s): Poster,
Countries: China, France, Germany, Italy, Japan, South Korea, Spain, UK,
C:
Y:
Oncology,
2018
  L:
A:
English
  Add to report
 
 
Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia
Author(s): Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3
Affiliations(s): 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA
Publication(s):  JCO ( ASCO 2018)
Document Type(s): Abstract,
Countries: Asia Pacific, China, Europe, France, Germany, Italy, Japan, South Korea, Spain, UK,
Click here for the abstract
C:
Y:
Oncology,
2018
  L:
A:
English
  Add to report
 
 
The health economic impact of optimizing post-hospitalization management for an exacerbation in COPD patients in China.
Author(s): Salem A1, Ramos M1, Hu H2, Zhong H3, Lamotte M1
Affiliations(s): 1 IQVIA, Zaventem, Belgium 2 University of Macau, Macau, China 3 AstraZeneca, Shanghai, China
Publication(s): 
Document Type(s): Poster,
Countries: China,
Click here for the abstract
C:
Y:
Health economics, Respiratory disease,
2018
  L:
A:
English
Cost analysis, Cost effectiveness,
  Add to report
 
 
The health economic impact of optimizing post-hospitalization management for an exacerbation in COPD patients in China.
Author(s): Salem A, Ramos M, Hu H, Zhong H, Lamotte M
Affiliations(s): IQVIA, Zaventem, Belgium
Publication(s):  ISPOR Asia Pacific, 2018, September 8-11, Tokyo, Japan
Document Type(s): Poster,
Countries: China,
C:
Y:
Health economics, Respiratory disease,
2018
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Cost-effectiveness of de-escalation from micafungin versus escalation from fluconazole for systemic candida infections in China
Author(s): Dechang Chen, Xianyao Wan, Eliza Kruger, Can Chen, Xiaomeng Yue, Liang Wang, Jiuhong Wu
Affiliations(s): IQVIA, Department of Critical Care Medicine, Shanghai Ruijin Hospital Affiliated To Jiaotong University, School of Medicine, Shanghai
Publication(s):  Journal of Medical Economics
Document Type(s): Article,
Countries: China,
Click here for the abstract
C:
Y:
Health economics, Infectious disease,
2018
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
 1 of 4 Next Page Last Page